Phage Therapy Market Size, Share, Growth, and Industry Analysis, By Type (DsDNA Bacteriophage, SsDNA Bacteriophage & SsRNA Bacteriophage), By Application (Animal Health, Aquaculture, Agriculture, Food Industry & Human Health) and Regional Forecast to 2033

PHAGE THERAPY MARKET REPORT OVERVIEW

Phage Therapy Market Size was estimated at USD 37.64 million in 2024 and it is expected to grow from USD 44.27 million in 2025 to USD 61.21 million by 2033. The Market CAGR (growth rate) is expected to be around 17.6% during the forecast period (2025 - 2033).

The overall market for phage therapy is growing progressively as the need for effective antibacterial agents has increased across the world as a result of the growing cases of antibiotic-resistant infections. This method is considered to be a localized, environmentally friendly, and effective means of fighting bacterial diseases; therefore, it can be regarded as a perspective in modern medicine and biotechnology. Phage therapy is expected to be an important tool in combating bacterial diseases all around the world when more and more functions in this field are discovered and developed.

• 

  Request a Free Sample to learn more about this report

COVID-19 Impact: Market Growth During Pandemic Due to increased R&D

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic was beneficial for the phage therapy market’s growth since the virus outbreak promoted R&D for solutions to bacterial infections that accompany viral diseases. Much focus and funds on the market focused on this concept, which was very important by showing the efficiency of phage therapy during the course of bacterial infections, not only through the pandemic but also way beyond it. The rising trend of public health awareness and control of infections has therefore stimulated the market’s growth and advancement.

LATEST TRENDS

"Innovative technologies drive phage therapy market growth through advanced applications"

The major new trends in the phage therapy market are the application of modern advances in genetic engineering, individualized phage therapy, and the creation of mixtures of bacteriophages, which can eliminate MRSA. One major development is the application of CRISPR-Cas systems to improve phage performance and selectivity, that is, bacterial targeting. It adds up to the efficiency of phage use and, at the same time, reduces the chances of developing bacterial resistance. Thus, the increasing use of such innovative technologies as phage therapy is steadily advancing and broadening the spectrum of possible uses.

• 

  Request a Free Sample to learn more about this report

SEGMENTATION

By Type

Based on type the market can be categorized into DsDNA Bacteriophage, SsDNA Bacteriophage & SsRNA Bacteriophage.

• DsDNA Bacteriophage: DsDNA bacteriophages can be considered as the most frequently used phages in therapy because of their reduced genomic simplicity and higher stability. They are efficient in identifying and destroying particular bacterial antagonists and, therefore, useful for treating different bacterial infections. They can transport bigger genetic loads; this means that there is potential for genetic promotions that could increase therapeutic effectivity.

• SsDNA Bacteriophage: SsDNA bacteriophages are rarer but are of considerable importance in phage therapy because they are simple and divide fast. These are capable of attacking and destroying particular bacteria, thus providing a different strategy to that of antibiotic-resistant bacteria. These organisms’ small genomes allow for genetic manipulation for the purpose of therapeutic treatment.

• SsRNA Bacteriophage: SsRNA bacteriophages are characterized based on their RNA genome, which is easy to mutate, more adaptive, and tends to mutate faster. They can be advantageous in the application of the phage therapy in light of their rapid mutational flexibility in exposing the bacteria's defenses. SsRNA phages are still not widely used; however, they can become constantly evolving approaches to bacterial infection treatment.

By Application

Based on application the market can be categorized into Animal Health, Aquaculture, Agriculture, Food Industry & Human Health.

• Animal Health: Phage therapy is applied in animal health to remove bacterial infections, particularly the ones in livestock, so as to reduce the usage of antibiotics leading to antibiotic resistance. This is helpful to increase the total health and production of the farm animals because this is clearly targeted to eliminate some bacterial types. This makes the food supply chain safer and sustainable soil use, which in turn makes it safe for farming.

• Aquaculture: The use of phage therapy in aquaculture is used in the control of bacterial diseases in fish and other aquaculture species, leading to enhancement of health and production of farmed aquatic animals. It is useful in excluding the aspect of antibiotics, which, in as much as they may be useful, can be deposited in seafood. The action of phage therapy that concerns the factor that harms pathogenic bacteria has a stably positive effect on the companies that are involved in the sphere of aquaculture.

• Agriculture: This security technology is applied to bacterial diseases affecting crops, where phage therapy helps enhance plant health and get luxurious crop production. The intervention is an eco-friendly approach to protecting plants from pests, and it lacks the complaints associated with chemical methods of pest control. The following method is not detrimental to the environment and helps in the achievement of the state of sustainable food production.

• Food Industry: Phage therapy is widely used in the food industry mainly to control bacterial contaminants that end up shortening the shelf life of the affected foods. The bacteriophages are working mainly on the pathogenic bacteria such as Salmonella, Listeria, and E. coli to reduce the foodborne diseases. This application also enables safer consumption, in addition to lifetime savings of money that are added from cutting off losses from products that have been spoiled or recalled.

• Human Health: It will be largely an extension of specific use of phage in human health involving the elimination of bacterial diseases with even a special focus on antibiotic-resistant ones. This strategy is distinctive and more advantageous compared to the use of broad-spectrum antibiotics, both topically on the affected area and systemically, which often has unwanted side effects. This therapy is one of the potentially effective measures that might help in getting rid of multidrug-resistant bacteria, thus giving people the chance to look forward to the improvement of treatment.

DRIVING FACTORS

"Antibiotic-resistant bacteria drive the market growth significantly"

The high frequency of antibiotic-resistant bacteria is one of the main factors that are responsible for the growth of the phage therapy market. This is where concerns with the effectiveness of traditional antibiotics arise and force people to look for something like phage therapy. Thus, the need for newer concepts is driving the research, development, and application of phage-based treatments.

"Antibiotic resistance drives the market growth, creating new demands"

The growing incidence of antibiotic-resistant bacteria is the key factor that fosters the phage therapy market. Meanwhile, there is a steady decline in the effectiveness of the conventional antibiotics, thus the search for other treatments like phage therapy. The treatments provided by phage-based therapies are consequently stimulating new demands for scientific and medical advancements.

RESTRAINING FACTOR

"Regulatory barriers hinder the market growth, limiting capital investment"

A major threat for the E-commerce SaaS Market Growth is the high regulatory barriers for approval of phage-based products for use in the clinic. Lack of standard protocols regarding the use of bacteriophages and phage therapy is limited due to regulatory issues and approvals, which acts as a concern for growing the market size of these therapies. Hence this uncertainty may hamper capital investment and therefore retard the advancement of growth in this market.

• 

  Request a Free Sample to learn more about this report

•  

PHAGE THERAPY MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America's Robust Infrastructure And R&D To Dominate The Market "

North America holds the largest market E-commerce SaaS Market Share because of the well-developed infrastructure of healthcare facilities, higher spending on research initiatives, and substantial firms that specialize in biotechnology. The regulatory conditions in the region are also beneficial to the development of novel therapies with the innovations in distinct harboring approval and commercialization of the phage treatments. Furthermore, the cases of antibiotic-resistant infections are prevalent in North America, forcing people to look for solutions like phage therapy. Altogether, these factors make North America ahead in the global phage therapy market.

KEY INDUSTRY PLAYERS

"Key players drive market growth through innovation and partnerships"

Key Industry Players pay a great attention to rapid development, implementation of new strategic partnerships, and trials for new Phage Therapy Market products. Their contribution concerning innovation, working with the regulations, and organizing awareness events is vital to building phage therapy as an additional antimicrobial class to broaden the respective market.

List of Market Players Profiled

• NPO Microgen (Russia)
• Proteon Pharmaceuticals (Poland)
• Phagelux (China)
• Intralytix (U.S)
• Micreos (Switzerland)

INDUSTRIAL DEVELOPMENT

April 18, 2024: Adaptive Phage Therapeutics announced their new PhageBank Expansion. This expansion involves adding a wider range of bacteriophages to their existing library, aimed at targeting multi-drug resistant bacterial infections. The enhanced PhageBank is designed to offer more precise and effective treatment options for patients with antibiotic-resistant infections, representing a significant advancement in personalized phage therapy.

REPORT COVERAGE

This report is based on historical analysis and forecast calculation that aims to help readers get a comprehensive understanding of the global Phage Therapy Market from multiple angles, which also provides sufficient support to readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the growth of the market by discovering the dynamic categories and potential areas of innovation whose applications may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points into consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.